Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCeltic Regulatory News (CCP)

Share Price Information for Celtic (CCP)

Share Price is delayed by 15 minutes
Get Live Data
256.00    5.00 (1.99%)
Bid:
246.00
Ask:
256.00
Spread: 10.00 (4.065%)
Market Cap: £243.43m
CCP Live PriceLast checked at - London Stock Exchange

Intraday Celtic Share Chart

Issue of Equity

19 Sep 2013 11:51

RNS Number : 4235O
Celtic PLC
19 September 2013
 



CELTIC PLC

Issued share capital

 

As a result of the issue on 2 September 2013 of 75,922 Ordinary Shares of 1p each ("Ordinary Shares") under the Company's scrip dividend reinvestment scheme, Celtic PLC's issued share capital as at 3 September 2013 was as follows:

 

91,254,614 Ordinary Shares of 1p each

13,855,193 Cumulative Convertible Preferred Ordinary Shares of 100p each

16,253,051 Cumulative Convertible Preference Shares of 60 p each

539,648,405 Deferred Shares of 1p each

 

Cumulative Convertible Preference Shares do not carry voting rights. Deferred Shares are not listed, are not transferable and carry no voting rights or substantive economic rights.

 

The above figures for Ordinary Shares and CPO Shares may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in voting rights under the FCA's Disclosure and Transparency Rules.

 

The new Ordinary Shares of 1p each allotted under the scrip scheme have been issued at a notional price of 57.2p each.

 

Application has been made for the admission of the 75,922 new Ordinary Shares of 1p each ("New Ordinary Shares") to trading on AIM. It is expected that dealings in these New Ordinary Shares, which will rank pari passu in all respects with the existing Ordinary Shares of the Company will commence on 25 September 2013.

 

Enquiries:

 

Michael Nicholson, Company Secretary 0141 551 4298

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEBKLFFXKFZBBD
Date   Source Headline
4th Jun 20183:56 pmRNSIssue of Equity
15th May 20183:22 pmRNSIssue of Equity
10th May 201812:00 pmRNSHolding(s) in Company
5th Apr 20185:15 pmRNSIssue of Equity
16th Mar 20184:05 pmRNSIssue of Equity
28th Feb 20184:26 pmRNSIssue of Equity
8th Feb 20184:05 pmRNSHalf-year Report
27th Dec 20177:00 amRNSIssue of Equity
20th Nov 20176:26 pmRNSIssue of Equity
15th Nov 20174:45 pmRNSResult of AGM
27th Oct 20173:12 pmRNSIssue of Equity
10th Oct 20177:00 amRNSNotice of AGM
4th Oct 20175:35 pmRNSIssue of Equity
20th Sep 20174:30 pmRNSFinal Results
1st Sep 20176:00 pmRNSIssue of Equity
31st Aug 20176:10 pmRNSIssue of Equity
15th Aug 20175:00 pmRNSIssue of Equity
4th Aug 20176:11 pmRNSScrip Dividend Price
21st Jul 20173:37 pmRNSDividend Timetable
2nd Jun 20174:00 pmRNSIssue of Equity
30th May 20177:00 amRNSDirectorate Change
18th May 20175:34 pmRNSHolding(s) in Company
3rd May 20176:10 pmRNSIssue of Equity
12th Apr 20176:15 pmRNSIssue of Equity
22nd Feb 20175:30 pmRNSIssue of Equity
6th Feb 20174:00 pmRNSHalf-year Report
18th Jan 20176:00 pmRNSIssue of Equity
9th Dec 20164:16 pmRNSAppointment of NED
16th Nov 20165:55 pmRNSResult of AGM
11th Nov 20162:20 pmRNSIssue of Equity
10th Oct 20164:00 pmRNSNotice of AGM
20th Sep 20162:59 pmRNSIssue of Equity
19th Sep 20163:00 pmRNSFinal Results
31st Aug 20167:00 amRNSIssue of Equity
15th Aug 20161:07 pmRNSIssue of Equity
5th Aug 20165:49 pmRNSScrip Dividend Price
15th Jul 20163:02 pmRNSDividend Timetable
14th Jul 20161:40 pmRNSIssue of Equity
17th Jun 20163:30 pmRNSIssue of Equity
17th May 20164:10 pmRNSIssue of Equity
3rd May 201611:00 amRNSIssue of Equity
1st Apr 201611:30 amRNSIssue of Equity
15th Mar 20165:54 pmRNSIssue of Equity
29th Feb 20162:15 pmRNSIssue of Equity
15th Feb 20167:00 amRNSIssue of Equity
12th Feb 20164:00 pmRNSInterim Results
1st Feb 20165:01 pmRNSIssue of Equity
27th Nov 20154:00 pmRNSAppointment of Financial Director
20th Nov 20154:20 pmRNSResult of AGM
17th Nov 20152:15 pmRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.